It has been recognized for over a decade that the nuclear magnetic resonance (NMR) relaxation data (the spin-lattice relaxation time, T1, and the spin-spin relaxation time T2) of the composite proton signal from tissues can be used to distinguish malignant from benign tissue. The use of proton T1 and T2 values for the detection of malignancy has, in the past year, begun to gain clinical relevancy, since NMR imaging instruments capable of making such measurements are beginning clinical trials. However, the use of proton relaxation data for detection of malignancy has neither the firm scientific foundation nor the quality of data which is required in order to differentiate between malignant and benign tissue with a level of confidence that is required in order to base clinical decisions on such NMR data. In order to improve this situation our overall goal in this research program is to test the hypothesis that by examination of the proton NMR spectrum and the relaxation data of each of its resolvable resonances resulting from the various classes of protons (water, aliphatic, aromatic, etc.) which contribute to the composite proton signal, a substantially improved basis for differentiation between malignant and benign tissue can be achieved. Such an improved basis will make possible diagnosis of malignancy by NMR imaging with high levels of confidence. Additionally, the information derived from these studies will be the basis for establishing a rational mechanism for the empirical findings. Preliminary studies in our laboratory have proven that this approach can be successful. We have shown in these studies that T1 values of certain individual resolvable proton resonances show a much greater difference between normal and malignant tissue than does the composite T1 of all proton resonances grouped together and that T1 values of other resonances (e.g. water) show little or no differences between normal and malignant tissue.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA036276-03
Application #
3173828
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1984-01-01
Project End
1986-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Fossel, E T; Zanella, C L; Fletcher, J G et al. (1994) Cell death induced by peroxidized low-density lipoprotein: endopepsis. Cancer Res 54:1240-8
McDonagh, J; Fossel, E T; Kradin, R L et al. (1992) Effects of tumor necrosis factor-alpha on peroxidation of plasma lipoprotein lipids in experimental animals and patients. Blood 80:3217-26
Fossel, E T; Fletcher, J G; McDonagh, J et al. (1991) Selective cytotoxicity of low-density lipoprotein to helper T cells of cutaneous T-cell lymphoma after photoperoxidation with 8-methoxypsoralen. J Natl Cancer Inst 83:1316-21
Fossel, E T; Hall, F M; McDonagh, J (1991) C-13 NMR spectroscopy of plasma reduces interference of hypertriglyceridemia in the H-1 NMR detection of malignancy. Application in patients with breast lesions. Breast Cancer Res Treat 18:99-110
Fossel, E T (1991) The NMR blood test for cancer: current status. Cancer Cells 3:173-82
Fossel, E T; Dvorak, H F; Carr, J M et al. (1990) Alteration of aliphatic lipid proton NMR linewidths by malignant tumors in guinea pigs. Eur J Cancer 26:29-32
Fossel, E T; Carr, J M; McDonagh, J (1986) Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N Engl J Med 315:1369-76